Enbrel and Gastric mucosal lesion - a phase IV clinical study of FDA data


Gastric mucosal lesion is reported only by a few people who take Enbrel.

The phase IV clinical study analyzes which people take Enbrel and have Gastric mucosal lesion. It is created by eHealthMe based on reports of 633,316 people who have side effects while taking Enbrel from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

633,316 people reported to have side effects when taking Enbrel.
Among them, 3 people (0.0%) have Gastric mucosal lesion.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 635,038 Enbrel users for its effectiveness, alternative drugs and more.

What is Gastric mucosal lesion?

Gastric mucosal lesion (lesion of stomach mucous membrane) is found to be associated with 475 drugs and 280 conditions by eHealthMe.

Number of Enbrel and Gastric mucosal lesion reports submitted per year:

Could Enbrel cause Gastric mucosal lesion?

Time on Enbrel when people have Gastric mucosal lesion *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Gastric mucosal lesion when taking Enbrel *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Gastric mucosal lesion when taking Enbrel *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 50 %
  • 60+: 50 %

Common drugs people take besides Enbrel *:

  1. Omeprazole: 1 person, 33.33%
  2. Methylprednisolone: 1 person, 33.33%
  3. Methotrexate: 1 person, 33.33%
  4. Medrol: 1 person, 33.33%
  5. Ketorolac Tromethamine: 1 person, 33.33%
  6. Diclofenac: 1 person, 33.33%

Common side effects people have besides Gastric mucosal lesion *:

  1. Hyperaemia (increase of blood flow to different tissues in the body): 1 person, 33.33%
  2. Gastric Ulcer (stomach ulcer): 1 person, 33.33%
  3. Gastric Haemorrhage (bleeding stomach): 1 person, 33.33%

Common conditions people have *:

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 33.33%
  2. Pain: 1 person, 33.33%
  3. Gastric Disorder (disease of stomach): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Enbrel and have Gastric mucosal lesion?

Check whether Gastric mucosal lesion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Gastric mucosal lesion and when was it recovered:

Expand to all the drugs that have ingredients of etanercept:

Alternative drugs to, pros and cons of Enbrel:

Common Enbrel side effects:

Browse all side effects of Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Gastric mucosal lesion treatments and more:

COVID vaccines that are related to Gastric mucosal lesion:

All the drugs that are associated with Gastric mucosal lesion:

All the conditions that are associated with Gastric mucosal lesion:

How the study uses the data?

The study uses data from the FDA. It is based on etanercept (the active ingredients of Enbrel) and Enbrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: